BLRX
BioLineRX
BLRX
BLRX
20 hedge funds and large institutions have $2.91M invested in BioLineRX in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$114K | |
| 2 | +$87.7K | |
| 3 | +$26.4K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$21.4K |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$17.7K |
Top Sellers
| 1 | -$1.03M | |
| 2 | -$730K | |
| 3 | -$135K | |
| 4 |
AWS
Atria Wealth Solutions
New York
|
-$2.66K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.26K |